NATH BIOGENES (INDIA)
Back to Cashflow Statement
|
NATH BIOGENES (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-3.79 Cr | ₹-2.13 Cr | ₹-7.78 Cr | ₹-1.67 Cr | ₹-22 Cr |
What is the latest Cash Flow from Financing Activities ratio of NATH BIOGENES (INDIA) ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-3.79 Cr |
| Mar2025 | ₹-2.13 Cr |
| Mar2024 | ₹-7.78 Cr |
| Mar2023 | ₹-1.67 Cr |
| Mar2022 | ₹-22 Cr |
How is Cash Flow from Financing Activities of NATH BIOGENES (INDIA) Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-3.79 Cr | Negative | |
| Mar2025 | ₹-2.13 Cr | Negative | |
| Mar2024 | ₹-7.78 Cr | Negative | |
| Mar2023 | ₹-1.67 Cr | Negative | |
| Mar2022 | ₹-22 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹284.7 Cr | -1.4% | -2% | -10.1% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,146.3 Cr | 13.4% | 2.5% | -33.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,327.2 Cr | 0.5% | 3.6% | 9.3% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,410.3 Cr | 2.7% | 6.5% | 24.5% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹923.8 Cr | 2% | -1.2% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹526.6 Cr | 0.8% | 9% | -0.1% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -1.4% |
-2% |
-10.1% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses